This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Reliv International Elects John Klimek To Its Board Of Directors

CHESTERFIELD, Mo., May 20 /PRNewswire-FirstCall/ -- Reliv International, Inc. (Nasdaq: RELV) announced today that shareholders have elected John M. Klimek to its board of directors.  Klimek becomes the ninth member of the Reliv board.

Klimek, 51, is managing director, legal, and chief compliance officer of HFR Asset Management, LLC, a hedge fund management company based in Chicago.  He has worked at HFR since 2004.

"John's knowledge of the financial markets as well as his understanding of direct selling will make him a valuable member of our board," said Robert L. Montgomery, Reliv's chairman, president and chief executive officer.

Klimek is a native of Chicago.  He earned a bachelor's degree in accountancy from the University of Illinois, and received his law degree from the University of Illinois law school.

About Reliv

Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements.  Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as blood-sugar management, energy and performance enhancement, women's health and anti-aging.  Reliv sells its products through an international network marketing system of approximately 66,000 independent distributors.  Additional information about Reliv International, Inc. can be obtained on the Web at www.reliv.com.

SOURCE Reliv International, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
RELV $1.20 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs